港股上市公司和铂医药-B（02142）今日盘中大涨11.62%，引起市场广泛关注。截至发稿，该股报价9.22港元。
消息面上，和铂医药在周末宣布与全球生物制药巨头阿斯利康（AstraZeneca）达成重要战略合作。根据协议，和铂医药将向AstraZeneca发行7627.17万股新股，每股作价10.74港元，较3月21日收盘价溢价37.2%，总融资额达1.05亿美元。完成后，AstraZeneca将持有和铂医药9.15%的股份。
此次合作不仅为和铂医药带来可观的资金支持，更重要的是双方将在新一代多特异性抗体研发方面展开深度合作。和铂医药有望获得高达44亿美元的研发及商业里程碑付款，以及未来产品销售的特许权使用费。这一战略合作极大地提升了市场对和铂医药未来发展前景的信心，推动其股价强势上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.